𝛼SK or Search

ENTITY

Avrobio Inc (AVRO US)

3

Analysis

Health Care • United States

Avrobio, Inc. operates as a bio-technology company. The Company develops step-change cell and gene therapies for the treatment of cancer and rare disease. Avrobio serves clients in the United States and Canada.

more

Refresh

Exchange Announcement • 21 Jun 2024 04:25

Current Report (Form 8-K | Period ending 2024-06-20)

Exchange Announcement • 18 Jun 2024 23:51

Current Report (Amendment) (Form 8-K/A | Period ending 2024-06-14)

Exchange Announcement • 15 Jun 2024 04:30

Current Report (Form 8-K | Period ending 2024-06-14)

Exchange Announcement • 12 Jun 2024 04:29

Current Report (Form 8-K | Period ending 2024-06-11)

Exchange Announcement • 04 Jun 2024 21:31

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x